بسم اهلل الرمحن الرحيم فمن شهد منكم الشهر

Size: px
Start display at page:

Download "بسم اهلل الرمحن الرحيم فمن شهد منكم الشهر"

Transcription

1 بسم اهلل الرمحن الرحيم فمن شهد منكم الشهر فليصمه

2 Najat Buzaid

3 Introduction

4 Ramadan is a lunar-based month, and its duration varies between 29 and 30 days.

5 The fasting hours vary from 10 hours in a temperature climate to 20 hours in hot climates, depending on the geographical location and time of Ramadan in the seasonal cycle.

6 There are about 1.9 billion Muslims worldwide. The prevalence of diabetes in middle east adult population is 7.7%.

7 Although diabetics may be exempted from fasting; many of them prefer not to accept the exemption

8 First international congress held in Casablanca, Morocco in January 1994, concluded that there is No major change in the baseline health during Ramadan.

9 The population-based Epidemiology of Diabetes and Ramadan (EPIDIAR) study 2001 demonstrated among 12,243 people with diabetes from 13 Islamic countries that 43% of patients with type 1 diabetes and 79% of patients with type 2 diabetes fast during Ramadan a minimum of 15 days (> 50 million people with diabetes fast during Ramadan).

10 In a study of 493 diabetic patients at Benghazi Diabetes and Endocrine Center; 70% of diabetic patients completed the 30 days of Ramadan fasting (Elmehdawi R 2oo8)

11

12 PATHOPHYSIOLOGY OF FASTING

13 Counter regulatory hormones

14 As fasting becomes protracted for more than several hours, glycogen stores become depleted, and the low levels of circulating insulin allow increased fatty acid release from adipocytes.

15 Oxidation of fatty acids generates ketones that can be used as fuel by skeletal and cardiac muscle, liver, kidney, and adipose tissue, thus sparing glucose for continued utilization by brain and erythrocytes.

16 The transition from a fed to a fasted state devided into three stages: 1) the postabsorptive phase, 6 24 h after beginning fasting 2) the gluconeogenic phase, (2 10 d) 3) the protein conservation phase, beyond 10 days of fasting. (Felig)

17 Effect of diabetes on fasting

18 In patients with type 1 diabetes, glucagon secretion may fail to increase appropriately in response to hypoglycemia. Epinephrine secretion is also defective in some patients with type 1 diabetes because of a combination of autonomic neuropathy and defects associated with recurrent hypoglycemia.

19 In patients with severe insulin deficiency, a prolonged fast in the absence of adequate insulin can lead to excessive glycogen breakdown and increased gluconeogenesis and ketogenesis, leading to hyperglycemia and ketoacidosis

20 Patients with type 2 diabetes may suffer similar perturbations in response to a prolonged fast; however, ketoacidosis is uncommon, and the severity of hyperglycemia depends on the extent of insulin resistance and/or deficiency.

21 In patients with diabetes, glucose homeostasis is influenced often by pharmacological agents designed to enhance or supplement insulin secretion

22 Insulin therapy augments fasting hypoglycemia, and counter regulatory response might be curtailed in the advanced disease leading to profound hypoglycemia

23 Risks associated with fasting in patients with diabetes

24 Hypoglycemia Hyperglycemia Diabetic ketoacidosis Dehydration and thrombosis

25 Dehydration and thrombosis Limitation of fluid intake during the fast, especially if prolonged, is a cause of dehydration. The dehydration may become severe as a result of excessive perspiration in hot and humid climates and among individuals who perform hard physical labor.

26 In addition, contraction of the intravascular space can further exacerbate the hypercoagulable state that is well demonstrated in diabetes. Increased blood viscosity secondary to dehydration may enhance the risk of thrombosis and stroke.

27 Categories of risk in patients with type 1 or type 2 diabetes who fast during Ramadan*

28 Very high risk Severe hypoglycemia within the 3 months prior to Ramadan A history of recurrent hypoglycemia Hypoglycemia unawareness Sustained poor glycemic control Ketoacidosis within the 3 months prior to Ramadan Acute illness Hyperosmolar hyperglycemic coma within the previous 3 m Performing intense physical labor Pregnancy Chronic dialysis

29 High risk Moderate hyperglycemia (average blood glucose mg/dl or A1C ( %) Renal insufficiency Advanced macrovascular complications Living alone and treated with insulin or sulfonylureas Patients with comorbid conditions. Old age with ill health Treatment with drugs that may affect mentation

30 Moderate risk Well-controlled diabetes treated with short-acting insulin secretagogues Low risk Well-controlled diabetes treated with lifestyle therapy, metformin, acarbose, thiazolidinediones, and/or incretin based therapies in otherwise healthy patient

31 Studies on diabetes and Ramadan Most papers on Ramadan and diabetes report survey data and only few controlled clinical assays were carried out on this subject. Results showed discrepancies that could be explained in terms of protocol differences.

32 Uysal A et al (1998) conducted a study on 41 type 2 diabetic patients (30 women, 11 men, mean age 55 years) to observe the clinical and metabolic effects of fasting. DIABETES CARE, VOLUME 21, NUMBER 11, NOVEMBER 1998

33 None of the patients experienced severe hypoglycemia or neuro glycopenic symptoms. No statistically significant change was observed in mean body weight, BMI, total cholesterol level, or LDL cholesterol level. DIABETES CARE, VOLUME 21, NUMBER 11, NOVEMBER 1998

34 The mean HDL cholesterol level increased significantly during Ramadan, and it was still significantly higher 3 weeks after Ramadan than that before Ramadan. The mean triglyceride level was significantly lower during the 4th week of Ramadan than it was before Ramadan DIABETES CARE, VOLUME 21, NUMBER 11, NOVEMBER 1998.#

35 The population-based Epidemiology of Diabetes and Ramadan Study 13 Countries, 12,243 people with diabetes Type 2 DM: (86.5%) mean age: 54 years Duration: 7.6 years Type 1 DM:(8.3%) mean age: 31 years Duration: 10 years D.M unclassified: (5.2%) Diabetes Care, October 2004 The EPIDIAR study

36 The incidence of severe hyperglycemia with or without ketoacidosis in patients with type 1 diabetes (from 5 to 17 events/100 people/ month). The incidence of severe hyperglycemia (requiring hospitalization) during Ramadan in patients with type 2 diabetes (from 1 to 5 events / 100 people /month). Diabetes Care, October 2004

37 fasting during Ramadan increased the risk of severe hypoglycemia (defined as hospitalization due to hypoglycemia) in patients with type 1 diabetes (from 3 to 14 events/100 people/month) and In patients with type 2 diabetes (from 0.4 to 3 events /100 people/month). Diabetes Care, October 2004

38 The incidence of severe hypoglycemia was probably underestimated in this study because events not requiring hospitalization were not included. DIABETES CARE, VOLUME 33, NUMBER 8, AUGUST 2010

39 Benghazi Diabetes and Endocrinology centre BDEC study, 2008 (n= 493) Population 493 patients 95% T2 Dm The incidence of hypoglycemia during Ramadan was 31 episodes/100 patients/ month Libyan J Med 2010

40 The incidence of sever hyperglycemia was 17 episodes/ 100 patients / month. Those who experienced sever hyperglycemia had a significantly high baseline HBA1C Libyan J Med 2010

41 Aquestionnaire survey conducted in Pakistan (n= 453) 2004 found that (72.5%) fasted during the month of Ramadan. (96.3%) of those who fasted were type II diabetics and fasted for an average of 25 days They found a prevalence of hypoglycaemia 21.7% for and hyperglycaemia 19.8%.

42 Diabetic ketoacidosis Elmehdwi et al, conducted A descriptive retrospective analysis of the records of all patients admitted with diabetic ketoacidosis to all Benghazi hospitals during the lunar year 1428 Hijri ( ). They found that 15 episodes occurred during Ramadan compared to a mean of 19.5 episodes/month during the other lunar months (p<0.001), and there was no significant difference in the mean age,mortality rate or in the length of hospitalization during Ramadan.

43 Body weight during Ramadan fasting In normal subjects: Weight losses of kg have been reported in normal weight individuals after they have fasted for the month of Ramadan.

44 In diabetics: A review of literature shows controversy about weight changes in diabetics during Ramadan.

45 In women with type 2 diabetes and a high body mass index (34.63 ± 3.29 kg/m2), fasting during Ramadan resulted in significant weight loss ( 3.12 kg; p < 0.01).

46 Blood glucose variations during Ramadan fasting in diabetics Most patients show no significant change in their glucose control. In some patients, serum glucose concentration may fall or rise.

47 In general, HbAIC values show no change or even improvement during Ramadan. The amount of fructosamine, insulin, C- peptide also has been reported to have no significant change before and during Ramadan fasting.

48 Serum lipid variables during Ramadan fasting in diabetics Most patients with diabetes show no change or a slight decrease in concentrations of total cholesterol and triglyceride.

49 Few studies have reported increases in high-density-lipoprotein (HDL) cholesterol in diabetics during Ramadan.#

50 Effects of fasting on cardiovascular endpoints A large population-based study conducted in Qatar, where 95% of the adult population fast for Ramadan, has shown no significant difference in hospital admissions for acute coronary syndrome between Ramadan and non fasting months. Heart 2004

51 Effects of fasting on cardiovascular endpoints A 13-year review of a stroke database also showed no significant difference in the number of hospitalizations for stroke during the fasting month of Ramadan as compared to other months. Singapore Med J. 2006

52 Summary and recommendations The large proportion of diabetic subjects who fast during Ramadan represent a challenge to provide more intensive education before fasting and to disseminate guidelines.

53 Summary and recommendations Serum glucose variations during Ramadan may be due to the amount or type of food consumed, changes in body weight and exercise habits, regularity of taking medications.

54 Newer pharmacological agents and insulin pump therapy may have specific advantages during Ramadan.

55 Ramadan focused education.

56 بسم اهلل الرمحن الرحيم وأن تصوموا خري لكم إن كنتم تعلمون

DIABETES AND RAMADAN FASTING

DIABETES AND RAMADAN FASTING DIABETES AND RAMADAN FASTING Dr. A. Nigam, M.B.B.S., M.D. (Medicine) Specialist Internal Medicine Al Zahrawi Hospital, Ras Al Khaimah, U.A.E. It is estimated that UAE s population currently stands at approximately

More information

Managing diabetes in Ramadan

Managing diabetes in Ramadan 2nd EASD Postgraduate Course on Clinical Diabetes and its Complications Shiraz, Iran, 2-4 March 2017 Managing diabetes in Ramadan Fereidoun Azizi, M.D. Farhad Hosseinpanah, M.D. Research institute for

More information

Hormonal Regulations Of Glucose Metabolism & DM

Hormonal Regulations Of Glucose Metabolism & DM Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order

More information

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from

More information

Does Technology helps adolescents with type 1 diabetes in fasting Ramadan?

Does Technology helps adolescents with type 1 diabetes in fasting Ramadan? Does Technology helps adolescents with type 1 diabetes in fasting Ramadan? Abdulmoein Al-Agha, FRCPCH Professor of Paediatric Endocrinology, King Abdulaziz University Hospital, http://aagha.kau.edu.sa

More information

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis

More information

Diabetes Mellitus. Diabetes Mellitus. Insulin. Glucose. Classifications of DM. Other glucose regulating Hormones

Diabetes Mellitus. Diabetes Mellitus. Insulin. Glucose. Classifications of DM. Other glucose regulating Hormones Diabetes Mellitus Diabetes Mellitus Pathophysiology Literally sweet urine Defined by excess blood serum glucose Normally all glucose in the PCT is reabsorbed by active transport When blood glucose is elevated,

More information

What systems are involved in homeostatic regulation (give an example)?

What systems are involved in homeostatic regulation (give an example)? 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview

More information

The Many Faces of T2DM in Long-term Care Facilities

The Many Faces of T2DM in Long-term Care Facilities The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment

More information

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free

More information

Diabetes Mellitus Case Study

Diabetes Mellitus Case Study COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Intermittent Fasting. Chan-Hee Jung Endocrinology and Metabolism Soonchunhyang University College of Medicine KDA Spring Conference

Intermittent Fasting. Chan-Hee Jung Endocrinology and Metabolism Soonchunhyang University College of Medicine KDA Spring Conference Intermittent Fasting Chan-Hee Jung Endocrinology and Metabolism Soonchunhyang University College of Medicine 2014-5-9 KDA Spring Conference Contents Fasting Physiology General molecular mechanisms for

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

METABOLISM CATABOLIC Carbohydrates Lipids Proteins

METABOLISM CATABOLIC Carbohydrates Lipids Proteins Index: - Overview: Catabolism and Anabolism. Few concepts:, NADPH. - Overview: Metabolism glucose, fatty acids and amino acids. - Table summary: Principal anabolic and catabolic pathways, and their main

More information

Diabetes Overview. How Food is Digested

Diabetes Overview. How Food is Digested Diabetes Overview You are The Teacher, The Coach and the Fan Pathophysiology of Diabetes Complications Know the Numbers Treatment Can Good Control Make a Difference? Can Tight Control Be too Tight? How

More information

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED QUIZ/TEST REVIEW NOTES SECTION 1 SHORT TERM METABOLISM [METABOLISM] Learning Objectives: Identify primary energy stores of the body Differentiate the metabolic processes of the fed and fasted states Explain

More information

Controversies in Neonatal Hypoglycemia PAC / LAC CONFERENCE, JUNE 1 ST 2017

Controversies in Neonatal Hypoglycemia PAC / LAC CONFERENCE, JUNE 1 ST 2017 Controversies in Neonatal Hypoglycemia PRIYA JEGATHEESAN, MD PAC / LAC CONFERENCE, JUNE 1 ST 2017 Disclosure I have no conflicts of interest to disclose Objectives Review Recommendations from different

More information

Chapter 24 Diabetes Mellitus

Chapter 24 Diabetes Mellitus Chapter 24 Diabetes Mellitus Classification of Diabetes Mellitus Acute Effects of Diabetes Mellitus Chronic Complications of Diabetes Mellitus: Early Stages Chronic Complications of Diabetes Mellitus:

More information

Combining Complex Pathophysiologic Concepts: Diabetes Mellitus

Combining Complex Pathophysiologic Concepts: Diabetes Mellitus Chapter 18 Combining Complex Pathophysiologic Concepts: Diabetes Mellitus KEY TERMS dawn phenomenon diabetes mellitus endocrine pancreas exocrine pancreas hyperglycemia hyperketonemia hypoglycemia insulin

More information

What s New on the Horizon: Diabetes Medication Update

What s New on the Horizon: Diabetes Medication Update What s New on the Horizon: Diabetes Medication Update Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors, and what s coming Revised ADA/EASD and AACE guidelines:

More information

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 7, 2012 VanderbiltHeart.com Outline

More information

Chief of Endocrinology East Orange General Hospital

Chief of Endocrinology East Orange General Hospital Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage

More information

Week 3 The Pancreas: Pancreatic ph buffering:

Week 3 The Pancreas: Pancreatic ph buffering: Week 3 The Pancreas: A gland with both endocrine (secretion of substances into the bloodstream) & exocrine (secretion of substances to the outside of the body or another surface within the body) functions

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND THE OLDER ADULT

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND THE OLDER ADULT Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND THE OLDER ADULT Objectives u At conclusion of the presentation the participant will: 1. Discuss challenges to glycemic control unique in the older population

More information

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA What s New on the Horizon: Diabetes Medication Update Michael Shannon, MD Providence Endocrinology, Olympia WA 1 Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors,

More information

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Diabetes Mellitus: Implications of New Clinical Trials and New Medications Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October

More information

Chapter 4. Risk Stratification of Individuals with Diabetes before Ramadan Monira Al-Arouj, Abdullah Ben-Nakhi & Mohamed Hassanein

Chapter 4. Risk Stratification of Individuals with Diabetes before Ramadan Monira Al-Arouj, Abdullah Ben-Nakhi & Mohamed Hassanein Chapter 4. Risk Stratification of Individuals with Diabetes before Ramadan Monira Al-Arouj, Abdullah Ben-Nakhi & Mohamed Hassanein 41 4.1 Risks associated with fasting in people with diabetes During Ramadan,

More information

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Genetics, environment, and lifestyle (obesity, inactivity, poor diet) Impaired fasting glucose Decreased β-cell

More information

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control Insulin Secretion Management of Type 2 Diabetes DG van Zyl Why Do We Bother to Achieve Good Control in DM2 % reduction 0-5 -10-15 -20-25 -30-35 -40 The Importance of BP and Glucose Control Effects of tight

More information

Overview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment.

Overview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment. Pål R. Njølstad MD PhD KG Jebsen Center for Diabetes Research University of Bergen, Norway Depertment of Pediatrics Haukeland University Hospital Broad Institute of Harvard & MIT Cambridge, MA, USA Hypoglycemia

More information

Welcome and Introduction

Welcome and Introduction Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for

More information

Fasting and Diabetes: An experience with safety of fasting in peoples with type II diabetes

Fasting and Diabetes: An experience with safety of fasting in peoples with type II diabetes : An experience with safety of fasting in peoples with type II diabetes Ahmed Bilal 1, Muhammad Sohail Anjum 2, Zaheer Ahmed 3 1 Chief Endocrinologist and Professor of Medicine, Head of Medical Unit II,

More information

Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type 2 Diabetes

Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type 2 Diabetes Draft Comparative Effectiveness Review Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type Diabetes Prepared for: Agency for Healthcare Research and Quality U.S. Department

More information

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care Mary Jean Christian, MA, MBA, RD, CDE Diabetes Program Coordinator UC Irvine Health Hot Topics: Diabetes

More information

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,

More information

Chapter 37: Exercise Prescription in Patients with Diabetes

Chapter 37: Exercise Prescription in Patients with Diabetes Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:

More information

Exercise in Diabetes Mellitus. Pranisa Luengratsameerung,MD

Exercise in Diabetes Mellitus. Pranisa Luengratsameerung,MD Exercise in Diabetes Mellitus By Pranisa Luengratsameerung,MD What is the Diabetes Mellitus? action Insulin Defect release Abnormal glucose metabolism Symptoms Polyuria (frequent urination) Polyphasia

More information

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia

More information

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes

More information

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology

More information

International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR)

International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) IJAMSCR Volume 3 Issue 1 Jan-Mar- 2015 www.ijamscr.com Research article Medical research Diabetes mellitus associated mortality:

More information

Diabetes Complications Recognition and Treatment

Diabetes Complications Recognition and Treatment Diabetes Complications Recognition and Treatment Edward Shahady MD, FAAFP, ABCL Clinical Professor Family Medicine Medical Director Diabetes Master Clinician Program Diabetes is the most difficult of all

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adolescents, increase in type 2 diabetes in, 480 Albuminuria, and neuropathy, exercise in, 435 Arterial disease, peripheral, tests for, to assess

More information

Lipids Carbohydrate Protein. Fatty Acids Glycerol. Mono/di-saccarides. Aminoacids. Fat Liver Muscle. Triglycerides Glycogen Protein

Lipids Carbohydrate Protein. Fatty Acids Glycerol. Mono/di-saccarides. Aminoacids. Fat Liver Muscle. Triglycerides Glycogen Protein Lipids Carbohydrate Protein Fatty Acids Glycerol Mono/di-saccarides Fat Liver Muscle Aminoacids Triglycerides Glycogen Protein Microvascular Macrovascular Diabetes-specific Diabetes-enhanced HbA1c 5.7(6.0)

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Proposed Health Technology Appraisal Dapagliflozin in combination therapy for the Final scope Remit/appraisal objective To appraise the clinical and

More information

Personalized therapeutics in diabetes

Personalized therapeutics in diabetes Personalized therapeutics in diabetes Leen M. t Hart Molecular Cell Biology & Molecular Epidemiology Leiden University Medical Center Epidemiology & Biostatistics VU University Medical Center Diabetes

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized

More information

ESPEN Congress Madrid 2018

ESPEN Congress Madrid 2018 ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and

More information

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management

More information

New Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed

New Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed New Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed Competency Pathophysiology 1.A Describes the pathophysiology and progression of all types of 1.B Distinguishes between

More information

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of

More information

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose).

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose). DIABETES WHAT IS DIABETES? Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose). Diabetes Insipidus (DI) Condition in which the body has lack

More information

Changing Diabetes: The time is now!

Changing Diabetes: The time is now! Midwest Cardiovascular Research Foundation Welcomes DANITA HARRISON, ARNP Ms. Harrison discloses speaking relationships with Lilly, Novo Nordisk and Pfizer. Changing Diabetes: The time is now! Danita Harrison

More information

Diabetes(Mellitus( Dr(Kawa(A.(Obeid( PhD!Therapeutics!

Diabetes(Mellitus( Dr(Kawa(A.(Obeid( PhD!Therapeutics! DiabetesMellitus DrKawaA.Obeid PhDTherapeutics 1 Definitionandabriefintroduction Diabetes mellitus is the most common of the endocrine disorders. It is primarily a disorder of carbohydratemetabolismcharacterisedbyhyperglycaemia,thisisduetoimpairedinsulinsecretion

More information

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS 10. ACUTE COMPLICATIONS OF DIABETES MELLITUS Prof. Oren Zinder, Ph.D. Rambam Medical Center, and the Technion Faculty of Medicine, Haifa, Israel 1.1. Hypoglycaemia Hypoglycaemia is a lowered blood glucose

More information

ERBP Guideline on management of diabetics with advanced CKD

ERBP Guideline on management of diabetics with advanced CKD ERBP Guideline on management of diabetics with advanced CKD ERBP Mission improve the outcome of patients with kidney disease in a sustainable way, through enhancing the accessibility of knowledge on patient

More information

Hormonal regulation of. Physiology Department Medical School, University of Sumatera Utara

Hormonal regulation of. Physiology Department Medical School, University of Sumatera Utara Hormonal regulation of nutrient metabolism Physiology Department Medical School, University of Sumatera Utara Homeostasis & Controls Successful compensation Homeostasis reestablished Failure to compensate

More information

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM WHAT IS DIABETES? DIABETES Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose). Diabetes Insipidus (DI) Condition in which the body has lack

More information

Complete Comprehensive Diabetes Educator modules available at CCCEP File #: I-P (Expires: Mar.

Complete Comprehensive Diabetes Educator modules available at   CCCEP File #: I-P (Expires: Mar. CDE Preparation Program Topics (Accredited by CCCEP for 0.5 CEUs/Module section Total = 20 CEUs) Module 1 Pathophysiology of Diabetes 5 segments Module 2 Diabetes and Nutrition 5 segments Module 3 Medications

More information

APPENDIX American Diabetes Association. Published online at

APPENDIX American Diabetes Association. Published online at APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Pathogenesis of Diabetes Mellitus

Pathogenesis of Diabetes Mellitus Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia

More information

The Endocrine Pancreas (Chapter 10) *

The Endocrine Pancreas (Chapter 10) * OpenStax-CNX module: m62118 1 The Endocrine Pancreas (Chapter 10) * Ildar Yakhin Based on The Endocrine Pancreas by OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons

More information

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Lipid Metabolism. Remember fats?? Triacylglycerols - major form of energy storage in animals

Lipid Metabolism. Remember fats?? Triacylglycerols - major form of energy storage in animals Remember fats?? Triacylglycerols - major form of energy storage in animals Your energy reserves: ~0.5% carbs (glycogen + glucose) ~15% protein (muscle, last resort) ~85% fat Why use fat for energy? 1 gram

More information

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:

More information

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar

More information

Rick Fox M.A Health and Wellness Specialist

Rick Fox M.A Health and Wellness Specialist Metabolic Diseases Rick Fox M.A Health and Wellness Specialist Metabolic Diseases Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates

More information

Diabetes Mellitus Aeromedical Considerations. Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013

Diabetes Mellitus Aeromedical Considerations. Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013 Diabetes Mellitus Aeromedical Considerations Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013 Metabolic, Nutritional or Endocrine disorders Applicants with metabolic, nutritional

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Energy metabolism - the overview

Energy metabolism - the overview Energy metabolism - the overview Josef Fontana EC - 40 Overview of the lecture Important terms of the energy metabolism The overview of the energy metabolism The main pathways of the energy metabolism

More information

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 17 Caring for Clients with Diabetes Mellitus Diabetes Mellitus Chronic disease Not a single disorder

More information

Nutritional Demands of Disease and Trauma

Nutritional Demands of Disease and Trauma Nutritional Demands of Disease and Trauma Lecture 89 2000 Northwestern University Medical School Nutritional Requirements Based on needs to support optimal physiological function Are changed by disease

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Inernal Medicine by Prof. El Sayed Abdel Fatah Eid. Diabetes Mellitus. Prof. El Sayed Abdel Fattah Eid. Lecturer of Internal Medicine Delta University

Inernal Medicine by Prof. El Sayed Abdel Fatah Eid. Diabetes Mellitus. Prof. El Sayed Abdel Fattah Eid. Lecturer of Internal Medicine Delta University Diabetes Mellitus By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University (Diabetes Mellitus) Definition: Diabetes mellitus comprises a heterogeneous group of metabolic diseases

More information

The endocrine pancreas. The integrated endocrine control of metabolism.

The endocrine pancreas. The integrated endocrine control of metabolism. The endocrine pancreas The integrated endocrine control of metabolism. Gabriella Kékesi 62. The endocrine pancreas. Identify the major hormones secreted from the endocrine pancreas (insulin, glucagon,

More information

Diabetes Education: A Comprehensive Review

Diabetes Education: A Comprehensive Review Diabetes Education: A Comprehensive Review Module 1: Pathophysiology and Prevention of Diabetes Planning Committee: Michael Boivin, B. Pharm. Johanne Fortier, BSc.Sc, BPh.LPh, CDE Carlene Oleksyn, B.S.P.

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Heart Failure Clin 2 (2006) 101 105 Index Note: Page numbers of article titles are in boldface type. A ACE inhibitors, in diabetic hypertension, 30 31 Adipokines, cardiovascular events related to, 6 Advanced

More information

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT Human Journals Research Article September 2015 Vol.:4, Issue:2 All rights are reserved by K. Saravanan et al. Effects of Monotherapy and Combination Therapy Involving Metformin and Glimepiride on HbA1c

More information

Nutritional Demands of Disease and Trauma

Nutritional Demands of Disease and Trauma al Demands of Disease and Trauma Lecture 89 Medical School al Requirements Based on needs to support optimal physiological function Are changed by disease or injury metabolism is altered to prevent further

More information

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015 Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have

More information

Individualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD

Individualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Individualizing Type 2 Diabetes Management Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Harsh Statistics 30.3 million (9.4% of population) in US had DM in 2015 The percent of population with DM increases

More information

Diabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel

Diabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance

More information

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013 DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes

More information

Metformin Hydrochloride

Metformin Hydrochloride Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin

More information

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia?

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia? Q99: At what plasma glucose level would glycosuria be expected? Q100: What is the cause of polyemia in hyperglycemia? Q101: What is the cause of polydipsia in the hypoglycemia? Q102: What is the effect

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS DIABETES MELLITUS 1. Introduction Diabetes is a global epidemic with 415 million people affected worldwide equivalent to the total population of the USA, Canada and Mexico. In recognition of this, the

More information

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ USADA can grant a Therapeutic Use Exemption (TUE) in compliance with the World Anti- Doping Agency International Standard for TUEs. The TUE application process

More information

Learning Objectives. At the conclusion of this module, participants should be better able to:

Learning Objectives. At the conclusion of this module, participants should be better able to: Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous

More information

Should Psychiatrists be diagnosing (and treating) metabolic syndrome

Should Psychiatrists be diagnosing (and treating) metabolic syndrome Should Psychiatrists be diagnosing (and treating) metabolic syndrome David Hopkins Clinical Director, Diabetes King s College Hospital, London Diabetes prevalence (thousands) Diabetes in the UK: 1995-2010

More information

Adult Diabetes Clinician Guide NOVEMBER 2017

Adult Diabetes Clinician Guide NOVEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.

More information

Principles of Anatomy and Physiology

Principles of Anatomy and Physiology Principles of Anatomy and Physiology 14 th Edition CHAPTER 25 Metabolism and Nutrition Metabolic Reactions Metabolism refers to all of the chemical reactions taking place in the body. Reactions that break

More information